Knockdown of SUMO-activating enzyme subunit 2 (SAE2) suppresses cancer malignancy and enhances chemotherapy sensitivity in small cell lung cancer

Sumoylation Pathway Is Required to Maintain the Basal Breast Cancer Subtype

(2014) Maria V. Bogachek et al.   CANCER CELL

MYC amplification is associated with poor survival in small cell lung cancer: a chromogenic in situ hybridization study

(2014) Rita de Cássia S. Alves et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

SUMO1 modification stabilizes CDK6 protein and drives the cell cycle and glioblastoma progression

(2014) Anita C. Bellail et al.   Nature Communications

MYC, MAX, and Small Cell Lung Cancer

(2014) C. M. Rudin et al.   Cancer Discovery

SUMO-specific protease 1 promotes prostate cancer progression and metastasis

(2012) Q Wang et al.   ONCOGENE

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

A Functional Role for Tumor Cell Heterogeneity in a Mouse Model of Small Cell Lung Cancer

(2011) Joaquim Calbo et al.   CANCER CELL

Increased expression of small ubiquitin-like modifier proteins in rectal adenocarcinoma patients after neoadjuvant chemoradiation

(2011) Rebecca Wiatrek et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Small-cell lung cancer

(2011) Jan P van Meerbeeck et al.   LANCET

A SUMOylation-Dependent Transcriptional Subprogram Is Required for Myc-Driven Tumorigenesis

(2011) J. D. Kessler et al.   SCIENCE

The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition

(2010) Jaclyn R. Gareau et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Regulation of p53 family members by the ubiquitin-like SUMO system

(2009) Per Stehmeier et al.   DNA REPAIR

Small Cell Lung Cancer

(2009) Taimur Sher et al.   MAYO CLINIC PROCEEDINGS

Bronchopulmonary neuroendocrine tumors

(2008) Bjorn I. Gustafsson et al.   CANCER